A retrospective, observational study to examine the effect of early tumor necrosis factor inhibitor use on rates of surgery for Crohn’s disease in Japan

Authors: Tetsuya Ishida

Source: BMC Gastroenterology, Vol 25, Iss 1, Pp 1-7 (2025)

Subject Terms: Tumor necrosis factor inhibitor, Crohn’s disease, Japan, Abdominal surgery, Infliximab, Adalimumab, Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: https://doaj.org/toc/1471-230X

Access URL: https://doaj.org/article/9b5ed4f75b2c4636a7e3c577739398c8

Difficult-to-treat rheumatoid arthritis: predictors and prevention possibilities (analysis of the Moscow unified register of arthritis data)

Authors: E. V. Zhilyaev, G. V. Lukina, E. N. Koltsova, E. I. Schmidt, K. A. Lytkina, I. V. Pozharov

Source: Klinicist, Vol 18, Iss 4, Pp 27-36 (2025)

Subject Terms: difficult-to-treat rheumatoid arthritis, predictor, tumor necrosis factor inhibitor, etanercept, abatacept, jak kinase inhibitor, rituximab, interleukin-6 inhibitor, cohort study, real clinical practice, Medicine

File Description: electronic resource

Relation: https://klinitsist.abvpress.ru/Klin/article/view/624; https://doaj.org/toc/1818-8338

Access URL: https://doaj.org/article/5d517e4a8cc74c6da22bc47ceb56b4cb

Dynamic changes in the gut microbiota composition during adalimumab therapy in patients with ulcerative colitis: implications for treatment response prediction and therapeutic targets

Authors: Han Na Oh, Seung Yong Shin, Jong-Hwa Kim, Jihye Baek, Hyo Jong Kim, Kang-Moon Lee, Soo Jung Park, Seok-Young Kim, Hyung-Kyoon Choi, Wonyong Kim, Woo Jun Sul, Chang Hwan Choi

Source: Gut Pathogens, Vol 16, Iss 1, Pp 1-11 (2024)

Subject Terms: Microbiome, Ulcerative colitis, Tumor necrosis factor inhibitor, Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: https://doaj.org/toc/1757-4749

Access URL: https://doaj.org/article/02afaa2d9d2c41fe86d2eafdf08aa8dc

Therapeutic single-cell landscape: methotrexate exacerbates interstitial lung disease by compromising the stemness of alveolar epithelial cells under systemic inflammationResearch in context

Authors: Sung Hae Chang, Seyoung Jung, Jeong Jun Chae, Jeong Yeon Kim, Seon Uk Kim, Ji Yong Choi, Hye-Jeong Han, Hyun Taek Kim, Hak-Jae Kim, Hyun Je Kim, Woong Yang Park, Jeffrey A. Sparks, Eun Young Lee, Jeong Seok Lee

Source: EBioMedicine, Vol 108, Iss , Pp 105339- (2024)

Subject Terms: Rheumatoid arthritis-associated interstitial lung disease, Methotrexate, Tumor necrosis factor inhibitor, SKG mouse, Macrophage differentiation, Th17 cell activation, Medicine, Medicine (General), R5-920

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S235239642400375X; https://doaj.org/toc/2352-3964

Access URL: https://doaj.org/article/377aa910c3d24ae484c505fd18e89172

A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry

Authors: Koshiro Sonomoto, Yoshihisa Fujino, Hiroaki Tanaka, Atsushi Nagayasu, Shingo Nakayamada, Yoshiya Tanaka

Source: Rheumatology and Therapy, Vol 11, Iss 3, Pp 709-736 (2024)

Subject Terms: Rheumatoid arthritis, Tumor necrosis factor inhibitor, Machine learning, Sparse modeling, Precision medicine, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/2198-6576; https://doaj.org/toc/2198-6584

Access URL: https://doaj.org/article/04fd46c42cbc42c1bcdb39a57a8dc9b2

Corrigendum: Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression

Authors: Silke Griepke, Emilie Grupe, Jes Sanddal Lindholt, Elizabeth Hvitfeldt Fuglsang, Lasse Bach Steffensen, Hans Christian Beck, Mia Dupont Larsen, Sissel Karoline Bang-Møller, Martin Overgaard, Lars Melholt Rasmussen, Kate Lykke Lambertsen, Jane Stubbe

Source: Frontiers in Cardiovascular Medicine, Vol 11 (2024)

Subject Terms: cardiovascular disease, abdominal aortic aneurysm, tumor necrosis factor inhibitor, translational research, vascular inflammation, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2024.1466614/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/6456bf763df3450b8beb7fcb825fb1b3

Risk of disease flare in spondyloarthritis patients after tapering tumor necrosis factor inhibitors: A meta-analysis and literature review

Authors: Min, Hong Ki ^{a, b}, Kim, Hae-Rim ^b, Lee, Sang-Heon ^b, Nam, Bora ^{c, d}, Shin, Ji Hui ^d, Kim, Tae-Hwan ^{c, d, ⁎}

Source: In International Immunopharmacology 15 June 2024 134

Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review

Authors: Michael M. Ward, Nima Madanchi, Ali Yazdanyar, Nehal R. Shah, Florina Constantinescu

Source: Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-18 (2023)

Subject Terms: Rheumatoid arthritis, Tumor necrosis factor inhibitor, Remission, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1478-6362

Access URL: https://doaj.org/article/86b9ea7e707e463b9fc7395a4d3aefd0

Do TNF Inhibitors Increase the Frequency of Thyroid Nodules in Axial-spondyloarthritis Patients? A Case–control Study

Authors: Esra Dilşat Bayrak, Ilknur Aktaş, Feyza Ünlü Özkan, Irem Buse Kurucu Zeytin, Kemal Sarı, Esin Derin Çiçek

Source: Boğaziçi Tıp Dergisi, Vol 10, Iss 3, Pp 185-189 (2023)

Subject Terms: axial spondyloarthritis, thyroid nodule, tumor necrosis factor inhibitor., Medicine

File Description: electronic resource

Relation: https://jag.journalagent.com/z4/download_fulltext.asp?pdir=bmj&un=BMJ-98216; https://doaj.org/toc/2149-0287

Access URL: https://doaj.org/article/5bf2cdaa43f84d5d9edef5e1f2b7b167

Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis

Authors: Jashin J. Wu, Ching An Wang, Greeta Jobson, David Davidson, Samaneh Kalirai, Julia Zhu, Manasi Suryavanshi, Mayank Mittal, Vardhaman Patel, Lauren Seigel

Source: Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)

Subject Terms: healthcare resource utilization, interleukin inhibitor, persistence, tumor necrosis factor inhibitor, Dermatology, RL1-803

File Description: electronic resource

Relation: https://doaj.org/toc/0954-6634; https://doaj.org/toc/1471-1753

Access URL: https://doaj.org/article/5b6db17de9fb40db8013d1b1a84cc912

Factors influencing prescribing the first add-on disease-modifying antirheumatic drugs in patients initiating methotrexate for rheumatoid arthritis

Authors: Yinan Huang, Satabdi Chatterjee, Sandeep K. Agarwal, Hua Chen, Michael L. Johnson, Rajender R. Aparasu

Source: Exploratory Research in Clinical and Social Pharmacy, Vol 11, Iss , Pp 100296- (2023)

Subject Terms: Rheumatoid arthritis, Tumor necrosis factor inhibitor biologics, Combination therapy, Methotrexate, Biological disease-modifying antirheumatic drugs, Pharmacy and materia medica, RS1-441

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S266727662300077X; https://doaj.org/toc/2667-2766

Access URL: https://doaj.org/article/f4f76651c906426f83f9cf56bcfd1c1d

Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment

Authors: Soo Min Ahn, Jonggi Choi, Byong Duk Ye, Suk-Kyun Yang, Ji Seon Oh, Yong‑Gil Kim, Chang-Keun Lee, Bin Yoo, Sang Hyoung Park, Seokchan Hong

Source: Gut and Liver, Vol 16, Iss 4, Pp 567-574 (2022)

Subject Terms: hepatitis b virus, biologics, immune-mediated inflammatory disease, tumor necrosis factor inhibitor, Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: http://gutnliver.org/journal/view.html?doi=10.5009/gnl210204; https://doaj.org/toc/1976-2283

Access URL: https://doaj.org/article/69def27738bd49578475b0ef6262bd89

Effect of tumor necrosis factor inhibitors on risk of cardiovascular disease in patients with axial spondyloarthritis

Authors: Oh Chan Kwon, Min-Chan Park

Source: Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-9 (2022)

Subject Terms: Axial spondyloarthritis, Cardiovascular risk, Tumor necrosis factor inhibitor, Inflammation, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1478-6362

Access URL: https://doaj.org/article/f34273d0c0664c8f8b07d60562699763

Effectiveness of tumor necrosis factor inhibitors in children with enthesitis-related arthritis: a single-center retrospective analysis

Authors: Tonghao Zhang, Shuoyin Huang, Yanli Guo, Jing Jin, Wu Yan, Panpan Wang, Yuying Fang, Yingying Liu, Yuting Pan, Zhidan Fan, Haiguo Yu

Source: Frontiers in Pediatrics, Vol 11 (2023)

Subject Terms: juvenile idiopathic arthritis, enthesitis-related arthritis, anti-tumor necrosis factor inhibitor, laboratory parameters, treatment, outcomes, Pediatrics, RJ1-570

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fped.2023.1122233/full; https://doaj.org/toc/2296-2360

Access URL: https://doaj.org/article/4942c30444e341b2a1ad6397307e6e61

Risk of cancer, cardiovascular disease, thromboembolism, and mortality in patients with rheumatoid arthritis receiving Janus kinase inhibitors: a real-world retrospective observational study using Korean health insurance data

Authors: Hong Ki Min, Hyeongsu Kim, Ho Jin Jeong, Se Hee Kim, Hae-Rim Kim, Sang-Heon Lee, KunSei Lee, Soon-Ae Shin, Jong Heon Park

Source: Epidemiology and Health, Vol 45 (2023)

Subject Terms: rheumatoid arthritis, cardiovascular disease, venous thromboembolism, cancer, janus kinase inhibitor, tumor necrosis factor inhibitor, Medicine

File Description: electronic resource

Relation: http://www.e-epih.org/upload/pdf/epih-45-e2023045.pdf; https://doaj.org/toc/2092-7193

Access URL: https://doaj.org/article/f678869c50ba4abc8bb7d5773eda7aa1

Tumor necrosis factor inhibitors for pediatric patients with SAPHO syndrome associated with acne conglobata

Authors: Shengyan Liu, Xia Wu, Yihan Cao, Zhaohui Li, Yuchen Liu, Mingwei Ma, Chen Li

Source: Pediatric Rheumatology Online Journal, Vol 20, Iss 1, Pp 1-3 (2022)

Subject Terms: Acne conglobata, Tumor necrosis factor inhibitor, SAPHO syndrome, Pediatrics, RJ1-570, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1546-0096

Access URL: https://doaj.org/article/d0c09dad6a504e73b47fe8e74d4dd57d

Living with Ulcerative Colitis in Japan: Biologic Persistence and Health-Care Resource Use

Authors: Danielle Bargo, Theo Tritton, Joseph C. Cappelleri, Marco DiBonaventura, Timothy W. Smith, Takanori Tsuchiya, Sean Gardiner, Irene Modesto, Tim Holbrook, Daniel Bluff, Taku Kobayashi

Source: Inflammatory Intestinal Diseases, Vol 6, Iss 4, Pp 186-198 (2021)

Subject Terms: adherence, tumor necrosis factor inhibitor, ulcerative colitis, health-care resource utilization, persistence, Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: https://www.karger.com/Article/FullText/519123; https://doaj.org/toc/2296-9403; https://doaj.org/toc/2296-9365

Access URL: https://doaj.org/article/7a6ded8a8a944227a1c15b6d75bcc505

Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea

Authors: Jae Yong Lee, Kyunghwan Oh, Hee Seung Hong, Kyuwon Kim, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Ho-Su Lee, Kyung-Wook Jo, Sang Hyoung Park

Source: BMC Gastroenterology, Vol 21, Iss 1, Pp 1-9 (2021)

Subject Terms: Inflammatory bowel diseases, Tuberculosis, Tumor necrosis factor inhibitor, Latent tuberculosis, Risk factors, Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: https://doaj.org/toc/1471-230X

Access URL: https://doaj.org/article/80e6ce36cfac49b09ce423507395b529

Selective inhibition of soluble tumor necrosis factor signaling reduces abdominal aortic aneurysm progression

Authors: Silke Griepke, Emilie Grupe, Jes Sanddal Lindholt, Elizabeth Hvitfeldt Fuglsang, Lasse Bach Steffensen, Hans Christian Beck, Mia Dupont Larsen, Sissel Karoline Bang-Møller, Martin Overgaard, Lars Melholt Rasmussen, Kate Lykke Lambertsen, Jane Stubbe

Source: Frontiers in Cardiovascular Medicine, Vol 9 (2022)

Subject Terms: cardiovascular disease, abdominal aortic aneurysm, tumor necrosis factor inhibitor, inflammation, translational research, vascular inflammation, Diseases of the circulatory (Cardiovascular) system, RC666-701

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcvm.2022.942342/full; https://doaj.org/toc/2297-055X

Access URL: https://doaj.org/article/83ae2b2ab7034aa38999cb096770559d

Safety of tumor necrosis factor inhibitor use in patients with concomitant malignancy

Authors: Hiep Phan, Rick A. Weideman, Daisha J. Cipher, Linda A. Feagins

Source: Intestinal Research, Vol 18, Iss 3, Pp 282-288 (2020)

Subject Terms: tumor necrosis factor inhibitor, neoplasms, inflammatory bowel disease, arthritis, rheumatoid, Medicine, Diseases of the digestive system. Gastroenterology, RC799-869

File Description: electronic resource

Relation: http://www.irjournal.org/upload/pdf/ir-2019-09140.pdf; https://doaj.org/toc/1598-9100; https://doaj.org/toc/2288-1956

Access URL: https://doaj.org/article/e637e779141142c6b9c550b49f37518f